In your stateTennessee
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
Economic Impact In Your State: Tennessee
$10.5B
Total output supported by biophamaceutical sector
$387,614
Total output supported by biophamaceutical sector
46,435
Total Jobs
12,142
Direct Jobs
Clinical Trials in Your State: Tennessee
1,016
TOTAL CLINICAL TRIALS
$380.5 million
INVESTED IN CLINICAL TRIALS
24,089
TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS
$1.04 billion
INVESTED IN CLINICAL TRIALS
Programs and Initiatives in Your State: Tennessee
State programs and initiatives to promote biopharmaceutical industry development
- ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT
BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE
STEM EDUCATION & WORKFORCE DEVELOPMENT
TARGETED STRATEGIES
VENTURE FINANCING